- Home
- CRVS vs CURV Comparison
CRVS vs CURV Comparison
Compare CRVS & CURV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- CURV
- Stock Information
- Founded
- CRVS 2014
- CURV 2001
- Country
- CRVS United States
- CURV United States
- Employees
- CRVS N/A
- CURV N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- CURV Clothing/Shoe/Accessory Stores
- Sector
- CRVS Health Care
- CURV Consumer Discretionary
- Exchange
- CRVS Nasdaq
- CURV Nasdaq
- Market Cap
- CRVS 305.4M
- CURV 215.9M
- IPO Year
- CRVS 2016
- CURV 2021
- Fundamental
- Price
- CRVS $5.75
- CURV $2.16
- Analyst Decision
- CRVS Strong Buy
- CURV Hold
- Analyst Count
- CRVS 4
- CURV 4
- Target Price
- CRVS $15.00
- CURV $4.00
- AVG Volume (30 Days)
- CRVS 518.7K
- CURV 482.6K
- Earning Date
- CRVS 08-07-2025
- CURV 09-04-2025
- Dividend Yield
- CRVS N/A
- CURV N/A
- EPS Growth
- CRVS N/A
- CURV N/A
- EPS
- CRVS N/A
- CURV 0.09
- Revenue
- CRVS N/A
- CURV $1,089,931,000.00
- Revenue This Year
- CRVS N/A
- CURV N/A
- Revenue Next Year
- CRVS N/A
- CURV N/A
- P/E Ratio
- CRVS N/A
- CURV $24.08
- Revenue Growth
- CRVS N/A
- CURV N/A
- 52 Week Low
- CRVS $2.54
- CURV $2.08
- 52 Week High
- CRVS $10.00
- CURV $7.25
- Technical
- Relative Strength Index (RSI)
- CRVS 65.10
- CURV 35.39
- Support Level
- CRVS $5.28
- CURV $2.13
- Resistance Level
- CRVS $5.64
- CURV $2.24
- Average True Range (ATR)
- CRVS 0.30
- CURV 0.10
- MACD
- CRVS 0.03
- CURV 0.05
- Stochastic Oscillator
- CRVS 77.70
- CURV 38.30
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand of apparel, intimates, and accessories in North America. The company is focused on fit and offers high-quality products across a broad assortment that includes tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of the e-commerce platform and stores. The company generates revenue from the sale of apparel, intimates, and accessories through its e-commerce platform and its store locations.